Home > Resources > Whitepapers > The Reasons for And Solutions to Chronic Drug Shortages in The United States

The Reasons for And Solutions to Chronic Drug Shortages in The United States

One of the more vexing and troubling public health policy issue that has plagued the US pharma industry, yet receiving less deserving public news coverage than other industry stories, has been the existence of chronic drug shortages since the turn of the 21st century. A drug shortage is defined in which the “total supply of all clinically interchangeable versions of an FDA-regulated drug is inadequate to meet the current or projected demand at the patient level.” While the annual number has dropped since the peak year of 2011, the issue of chronic drug shortages still persists, despite attempts by the FDA and federal legislation to remedy the problem. Drug shortages continue to be severe enough to potentially cause adverse effects on patients, changes in treatment that result in suboptimal care, and higher costs to the healthcare system.

I'm For Real

Enter your details once to access all our information and resources

Spotlight

Primary Health Care Limited

At Primary Health Care, our purpose is to help all Australians be healthy and well. Our extensive network of medical centers with General Practice, pathology labs, diagnostic imaging and more offer patients the convenience of seamless medical services, whilst Healthcare Practitioners enjoy working in unique multi-disciplinary environments where they can pursue clinical excellence and innovative care. We are committed to shaping the future of Australian healthcare. From a single medical centre in 1985, our passion for delivering total care has seen us become the choice of over 2 million Australian patients.

OTHER WHITEPAPERS
news image

Reimagining the pharma landscape with design thinking

whitePaper | July 29, 2021

As pharma companies strive for increased commercial success the customer-centric focus can get lost in the adoption of new commercial endeavours. As a result, many have been looking toward the world of design as a way of enhancing their customer engagement and accelerating their position in the market.

Read More
news image

Multi-channel clinical trial recruitment technology checklist

whitePaper | August 8, 2022

Biopharma R&D professionals generally admit that the current "high-cost, high-risk" development model is unsustainable. Despite technological.

Read More
news image

The Annual Clinical Trials Round-up 2021

whitePaper | October 13, 2022

In our previous edition of the Clinical Trials Roundup1, we explored the acute disruptions that the COVID-19 pandemic brought to the clinical trials landscape in 2020.

Read More
news image

Infosys and Top Pharma Bring Digital Transformation to DrugManufacturing Data

whitePaper | April 1, 2022

In 2017, a top 20 global pharmaceutical company began a journey to digitally transform its pharmaceutical engineering and manufacturing capabilities by constructing a data integration and visualization platform, with strategic assistance and technical implementation provided by its partner Infosys.

Read More
news image

National Council for Prescription Drug Programs

whitePaper | May 12, 2022

This document is Copyright © 2022 by the National Council for Prescription Drug Programs (NCPDP). It may be freely redistributed in its entirety provided this copyright notice is not removed.

Read More
news image

Best Practices for RIM Business Process Automation

whitePaper | December 29, 2022

Regulatory teams at life science companies are finding that effective regulatory information management (RIM) has become critical to their operations.

Read More

Reimagining the pharma landscape with design thinking

whitePaper | July 29, 2021

As pharma companies strive for increased commercial success the customer-centric focus can get lost in the adoption of new commercial endeavours. As a result, many have been looking toward the world of design as a way of enhancing their customer engagement and accelerating their position in the market.

Read More

Multi-channel clinical trial recruitment technology checklist

whitePaper | August 8, 2022

Biopharma R&D professionals generally admit that the current "high-cost, high-risk" development model is unsustainable. Despite technological.

Read More

The Annual Clinical Trials Round-up 2021

whitePaper | October 13, 2022

In our previous edition of the Clinical Trials Roundup1, we explored the acute disruptions that the COVID-19 pandemic brought to the clinical trials landscape in 2020.

Read More

Infosys and Top Pharma Bring Digital Transformation to DrugManufacturing Data

whitePaper | April 1, 2022

In 2017, a top 20 global pharmaceutical company began a journey to digitally transform its pharmaceutical engineering and manufacturing capabilities by constructing a data integration and visualization platform, with strategic assistance and technical implementation provided by its partner Infosys.

Read More

National Council for Prescription Drug Programs

whitePaper | May 12, 2022

This document is Copyright © 2022 by the National Council for Prescription Drug Programs (NCPDP). It may be
freely redistributed in its entirety provided this copyright notice is not removed.

Read More

Best Practices for RIM Business Process Automation

whitePaper | December 29, 2022

Regulatory teams at life science companies are finding that
effective regulatory information management (RIM) has become critical to their operations.

Read More
More Whitepapers

Spotlight

Primary Health Care Limited

At Primary Health Care, our purpose is to help all Australians be healthy and well. Our extensive network of medical centers with General Practice, pathology labs, diagnostic imaging and more offer patients the convenience of seamless medical services, whilst Healthcare Practitioners enjoy working in unique multi-disciplinary environments where they can pursue clinical excellence and innovative care. We are committed to shaping the future of Australian healthcare. From a single medical centre in 1985, our passion for delivering total care has seen us become the choice of over 2 million Australian patients.

Events